EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Molecular Biomarkers of Radiosensitivity and Radioresistance in Cervical Cancer: A Systematic Review

Anamaria Hermina Girbovan iD, Cristina Balan iD, Alexandra Timea Kirsch-Mangu iD, Eva Fischer-Fodor iD, Patriciu Achimas-Cadariu iD

International Journal of Molecular Sciences · 05.08.2026 · 27 (15) · 7033

DOI: 10.3390/ijms27157033 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.08.2026. Verfasst von Anamaria Hermina Girbovan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Radiation Tolerance, Biomarkers, Tumor. Die Arbeit nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The primary aim of this review is to summarize current evidence from clinical and pre-clinical studies on endogenous molecular biomarkers associated with radiosensitivity and radioresistance in cervical cancer, including patients treated with photon-based radiotherapy, cervical cancer cell lines, and xenograft models, and to evaluate the association of these biomarkers with radiotherapy response, residual disease, recurrence and survival, and experimental measures of radiosensitivity. A systematic literature review was conducted for studies published over the last 10 years that evaluated associations between genomic, epigenetic, or protein biomarkers and radiotherapy response or survival outcomes in cervical cancer. Eligible studies included in the current analysis summarize clinical, translational, and pre-clinical studies in correlation with photon-based radiotherapy. Research focusing exclusively on non-coding RNAs, exogenous radiosensitizers, or non-photon modalities was excluded. In total, 112 studies were identified, and 46 of them met the inclusion criteria. The identified biomarkers clustered into several key biological processes: DNA damage response and cell cycle regulation, cancer stemness, hypoxia and microenvironment, epigenetic and transcriptional regulation, and signaling pathways, including exosome-mediated communication. Most markers were linked to radioresistance and adverse outcomes, whereas a smaller subset was associated with increased radiosensitivity. A limited group of biomarkers was linked to clinical outcomes such as local control, residual disease, or survival, and emerging multi-marker protein signatures suggested that combinatorial approaches may outperform single-marker strategies. Radiosensitivity in cervical cancer is regulated by a network of biological pathways. Validated, integrated biomarker panels that capture DNA repair proficiency, stemness, hypoxia adaptation, and key signaling pathways are needed to improve risk stratification and enable biomarker-guided radiosensitization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsRadiation ToleranceBiomarkers, TumorHumansFemaleAnimalsSignal TransductionEpigenesis, GeneticGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

DNA damage responsebiomarkerscancer stem cellshypoxiaradioresistanceradiotherapysignaling pathwaystumoruterine cervical neoplasms

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Radiation Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Department of Radiation Oncology, County Hospital Mures, 540072 Târgu Mureș, Romania.
  • Department of Medical Physics, "Prof. Dr. I. Chiricuta" Institute of Oncology, 400015 Cluj-Napoca, Romania.
  • Department of Radiation Oncology, "Prof. Dr. I. Chiricuta" Institute of Oncology, 400015 Cluj-Napoca, Romania.
  • Tumor Biology Department, "Prof. Dr. I. Chiricuta" Institute of Oncology, 400015 Cluj-Napoca, Romania.
  • Department of Surgical Oncology and Gynecologic Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

ORCID-Profile: Anamaria Hermina Girbovan, Cristina Balan, Alexandra Timea Kirsch-Mangu, Eva Fischer-Fodor, Patriciu Achimas-Cadariu

Zitieren

APA

Girbovan, A. H., Balan, C., Kirsch-Mangu, A. T., Fischer-Fodor, E., & Achimas-Cadariu, P. (2026). Molecular Biomarkers of Radiosensitivity and Radioresistance in Cervical Cancer: A Systematic Review. International Journal of Molecular Sciences, 27(15), 7033. https://doi.org/10.3390/ijms27157033

Vancouver

Girbovan AH, Balan C, Kirsch-Mangu AT, Fischer-Fodor E, Achimas-Cadariu P. Molecular Biomarkers of Radiosensitivity and Radioresistance in Cervical Cancer: A Systematic Review. International Journal of Molecular Sciences. 2026;27(15):7033. doi:10.3390/ijms27157033

BibTeX
@article{Girbovan2026,
  author = {Girbovan, Anamaria Hermina and Balan, Cristina and Kirsch-Mangu, Alexandra Timea and Fischer-Fodor, Eva and Achimas-Cadariu, Patriciu},
  title = {Molecular Biomarkers of Radiosensitivity and Radioresistance in Cervical Cancer: A Systematic Review},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {15},
  pages = {7033},
  doi = {10.3390/ijms27157033}
}
Kostenlos starten →